Browsing by Author "Eastlake, Leonie"
Now showing items 1-1 of 1
-
A Multicentre Retrospective Analysis of Toxicity in 6-weekly Versus 3-weekly Pembrolizumab
Rowe, Michael; Eastlake, Leonie; Norris, Timothy; Farley, Timothy; Talbot, Toby (Elsevier, 2021-05-01)Pembrolizumab is an anti-programmed cell death protein 1 immune checkpoint inhibitor with a dosing schedule of 200 mg 3 weekly (q3w). Dose of 400 mg 6 weekly (q6w) was approved based on simulation of dose/exposure relationships ...